13-85794096-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_032229.3(SLITRK6):​c.2413T>C​(p.Tyr805His) variant causes a missense change. The variant allele was found at a frequency of 0.000157 in 1,613,064 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

SLITRK6
NM_032229.3 missense

Scores

4
9
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 7.14
Variant links:
Genes affected
SLITRK6 (HGNC:23503): (SLIT and NTRK like family member 6) This gene encodes a member of the SLITRK protein family. Members of this family are integral membrane proteins that are characterized by two N-terminal leucine-rich repeat (LRR) domains and a C-terminal region that shares homology with trk neurotrophin receptors. This protein functions as a regulator of neurite outgrowth required for normal hearing and vision. Mutations in this gene are a cause of myopia and deafness. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLITRK6NM_032229.3 linkc.2413T>C p.Tyr805His missense_variant Exon 2 of 2 ENST00000647374.2 NP_115605.2 Q9H5Y7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLITRK6ENST00000647374.2 linkc.2413T>C p.Tyr805His missense_variant Exon 2 of 2 NM_032229.3 ENSP00000495507.1 Q9H5Y7
SLITRK6ENST00000643778.1 linkc.2413T>C p.Tyr805His missense_variant Exon 3 of 3 ENSP00000496428.1 Q9H5Y7

Frequencies

GnomAD3 genomes
AF:
0.000224
AC:
34
AN:
151936
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000329
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000230
AC:
57
AN:
247932
Hom.:
0
AF XY:
0.000201
AC XY:
27
AN XY:
134462
show subpopulations
Gnomad AFR exome
AF:
0.000518
Gnomad AMR exome
AF:
0.000611
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000205
Gnomad OTH exome
AF:
0.000831
GnomAD4 exome
AF:
0.000150
AC:
219
AN:
1461010
Hom.:
0
Cov.:
31
AF XY:
0.000154
AC XY:
112
AN XY:
726824
show subpopulations
Gnomad4 AFR exome
AF:
0.000389
Gnomad4 AMR exome
AF:
0.000627
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000133
Gnomad4 OTH exome
AF:
0.000381
GnomAD4 genome
AF:
0.000224
AC:
34
AN:
152054
Hom.:
0
Cov.:
32
AF XY:
0.000229
AC XY:
17
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.000361
Gnomad4 AMR
AF:
0.000328
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000177
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000233
Hom.:
0
Bravo
AF:
0.000257
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000531
AC:
2
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.000182
AC:
22
EpiCase
AF:
0.000218
EpiControl
AF:
0.000296

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Apr 06, 2020
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Apr 21, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1197937). This variant has not been reported in the literature in individuals affected with SLITRK6-related conditions. This variant is present in population databases (rs200882739, gnomAD 0.06%). This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 805 of the SLITRK6 protein (p.Tyr805His). -

Inborn genetic diseases Uncertain:1
Sep 16, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.2413T>C (p.Y805H) alteration is located in exon 2 (coding exon 1) of the SLITRK6 gene. This alteration results from a T to C substitution at nucleotide position 2413, causing the tyrosine (Y) at amino acid position 805 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

SLITRK6-related disorder Uncertain:1
Mar 25, 2024
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

The SLITRK6 c.2413T>C variant is predicted to result in the amino acid substitution p.Tyr805His. This variant has been reported in an individual with hearing loss (El Naofal et al 2023. PubMed ID: 36703223). This variant is reported in 0.060% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

High myopia-sensorineural deafness syndrome Uncertain:1
Feb 11, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Benign
-0.090
T
BayesDel_noAF
Uncertain
0.0
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.39
T;T;T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
.;.;D
M_CAP
Benign
0.054
D
MetaRNN
Uncertain
0.43
T;T;T
MetaSVM
Benign
-0.30
T
MutationAssessor
Uncertain
2.1
M;M;M
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-1.9
.;N;.
REVEL
Uncertain
0.37
Sift
Pathogenic
0.0
.;D;.
Sift4G
Uncertain
0.0070
.;D;.
Polyphen
1.0
D;D;D
Vest4
0.81
MVP
0.93
MPC
0.33
ClinPred
0.061
T
GERP RS
5.8
Varity_R
0.38
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200882739; hg19: chr13-86368231; API